OBJECTIVES: To test the hypothesis that a nocturnal decrease of secretion of inflammation markers and catecholamines would be associated with mood and stress variables even after controlling for objective sleep variables. METHODS: A total of 130 healthy volunteers participated in this study, spending 2 nights in the Gillin Laboratory of Sleep and Chronobiology at the University of California, San Diego, General Clinical Research Center. Blood samples were obtained before sleep (10:30 PM) and after awakening (6:30 AM) on the first day, and these samples were assayed for inflammatory biomarkers and catecholamines. On the second night, polysomnographic records were scored for objective sleep variables, e.g., total sleep time and wake after sleep onset. Self-rating scales for mood, stress, depression, and daily hassles were administered the second day. RESULTS: The nocturnal decrease in interleukin-6 was smaller in people who reported more negative mood or fatigue and greater in those who reported more uplift events (e.g., with Profile of Mood States fatigue r(p) = -.25 to -.30). People with high stress or high depression levels had smaller nocturnal decreases of epinephrine. That relationship was even stronger when partial correlations were used to control for morning level and sleep variables. The associations between nocturnal changes of C-reactive protein, soluble tumor necrosis factor-receptor I, and norepinephrine with psychological states were nonremarkable. CONCLUSIONS: The analyses of nocturnal change scores (difference scores) add substantial information compared with the traditional analyses of morning levels of immune variables and catecholamines alone. Subjective well-being is significantly associated with a greater nocturnal decrease of interleukin-6 and epinephrine. More research on nocturnal adaptation processes is warranted.
OBJECTIVES: To test the hypothesis that a nocturnal decrease of secretion of inflammation markers and catecholamines would be associated with mood and stress variables even after controlling for objective sleep variables. METHODS: A total of 130 healthy volunteers participated in this study, spending 2 nights in the Gillin Laboratory of Sleep and Chronobiology at the University of California, San Diego, General Clinical Research Center. Blood samples were obtained before sleep (10:30 PM) and after awakening (6:30 AM) on the first day, and these samples were assayed for inflammatory biomarkers and catecholamines. On the second night, polysomnographic records were scored for objective sleep variables, e.g., total sleep time and wake after sleep onset. Self-rating scales for mood, stress, depression, and daily hassles were administered the second day. RESULTS: The nocturnal decrease in interleukin-6 was smaller in people who reported more negative mood or fatigue and greater in those who reported more uplift events (e.g., with Profile of Mood States fatigue r(p) = -.25 to -.30). People with high stress or high depression levels had smaller nocturnal decreases of epinephrine. That relationship was even stronger when partial correlations were used to control for morning level and sleep variables. The associations between nocturnal changes of C-reactive protein, soluble tumor necrosis factor-receptor I, and norepinephrine with psychological states were nonremarkable. CONCLUSIONS: The analyses of nocturnal change scores (difference scores) add substantial information compared with the traditional analyses of morning levels of immune variables and catecholamines alone. Subjective well-being is significantly associated with a greater nocturnal decrease of interleukin-6 and epinephrine. More research on nocturnal adaptation processes is warranted.
Authors: Daniel Neu; Olivier Mairesse; Guy Hoffmann; Jean-Baptiste Valsamis; Paul Verbanck; Paul Linkowski; Olivier Le Bon Journal: Neuroepidemiology Date: 2010-03-25 Impact factor: 3.282
Authors: Lianne Tomfohr; Denise C Cooper; Paul J Mills; Richard A Nelesen; Joel E Dimsdale Journal: Psychosom Med Date: 2010-02-02 Impact factor: 4.312
Authors: Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Helena Liu; Lauren Sham; Elyse K Reim; Krista L Lanctôt Journal: Biol Psychiatry Date: 2009-12-16 Impact factor: 13.382
Authors: Angelo Scuteri; Gianfranco Spalletta; Marcello Cangelosi; Walter Gianni; Antonio Assisi; Anna Maria Brancati; Anna Modestino; Carlo Caltagirone; Massimo Volpe Journal: Aging Clin Exp Res Date: 2009 Aug-Oct Impact factor: 3.636
Authors: Seithikurippu R Pandi-Perumal; Adam Moscovitch; Venkatramanujam Srinivasan; David Warren Spence; Daniel P Cardinali; Gregory M Brown Journal: Prog Neurobiol Date: 2009-05-18 Impact factor: 11.685
Authors: Bartłomiej Wilkowski; Marcelo Fiszman; Christopher M Miller; Dimitar Hristovski; Sivaram Arabandi; Graciela Rosemblat; Thomas C Rindflesch Journal: AMIA Annu Symp Proc Date: 2011-10-22
Authors: Kristine A Donovan; Kevin D Stein; Morgan Lee; Corinne R Leach; Onaedo Ilozumba; Paul B Jacobsen Journal: Support Care Cancer Date: 2014-08-22 Impact factor: 3.603
Authors: Arun S Karlamangla; Sharon Stein Merkin; David M Almeida; Esther M Friedman; Jacqueline A Mogle; Teresa E Seeman Journal: J Gerontol B Psychol Sci Soc Sci Date: 2019-01-01 Impact factor: 4.077